Understand the source comparison
Peptides Help with Fat Burning: Dosage, Timing, and Practical Comparison
CJC-1295 + Ipamorelin GH secretagogue (pituitary stimulation) 100–200mcg each, combined 1–2× daily (preferably before bed and post-workout) Moderate. Multiple Phase 2 trials show 1–2kg fat loss over 12 weeks when paired with caloric deficit Best option for ind
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- CJC-1295 + Ipamorelin
- GH secretagogue (pituitary stimulation)
- 100–200mcg each, combined
- 1–2× daily (preferably before bed and post-workout)
- Moderate. Multiple Phase 2 trials show 1–2kg fat loss over 12 weeks when paired with caloric deficit
- Best option for indirect lipolysis via GH amplification; synergistic pairing required for peak efficacy
- AOD-9604
- Direct beta-3 adrenergic receptor agonist on adipocytes
- 250–500mcg daily
- Once daily (morning, fasted)
- Weak. Phase 2 data shows modest effect; Phase 3 trials failed to meet primary endpoints
- Mechanistically sound but underpowered in clinical trials; useful for studying fat-selective lipolysis without systemic GH effects
- Tesofensine
- Triple monoamine reuptake inhibitor (norepinephrine, dopamine, serotonin)
- 0.5–1mg daily
- Once daily (morning)
- Strong. Phase 3 trials demonstrate 9–11% body weight reduction over 24 weeks with sustained effect
- Most clinically robust peptide for appetite suppression and thermogenesis; cardiovascular monitoring required due to heart rate elevation
- Mazdutide / Survodutide
- Dual GLP-1/GIP receptor agonist
- 3–6mg weekly (titrated)
- Once weekly subcutaneous injection
- Emerging. Phase 2 data shows 15–18% body weight reduction; Phase 3 trials ongoing
- Represents next-generation peptide approach; combines appetite suppression with improved insulin sensitivity and lipid metabolism
- Dosing precision is critical. Growth hormone secretagogues are typically dosed at 100–200mcg per injection, administered subcutaneously in the abdominal region. Timing matters. GH secretagogues work best when administered during natural GH pulse windows (late evening or immediately post-exercise) because they amplify endogenous release rather than replacing it. Administering CJC-1295 or ipamorelin mid-morning, when cortisol levels are elevated and GH is naturally suppressed, produces minimal effect.
- Reconstitution is where most errors occur. Lyophilized peptides must be mixed with bacteriostatic water at the correct concentration. Typically 1–2mg peptide per 1mL water. And stored at 2–8°C after reconstitution. Peptides are fragile molecules; exposure to temperatures above 8°C causes irreversible denaturation. A vial left at room temperature for four hours is functionally inert, even if it appears clear and unchanged.